Related Experiment Video
Updated: Aug 27, 2025

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
Published on: October 30, 2013
How long should we follow patients managed for muscle-invasive bladder cancer? Lesson learned from a recent clinical
Aldo Franco De Rose1, Francesco Vecco2, Francesca Ambrosini3
1IRCCS Ospedale Policlinico San Martino, Genova. aldofrancoderose@gmail.com.
Abstract:
To the Editor, The exact time to stop bladder cancer patient's follow-up is not well known and there is not a clear recommendation on if and when stop to follow a patient managed for muscle invasive bladder cancer (MIBC). Major urological guidelines do not provide a precise indication on the timing of follow-up, and there is currently no real consensus on optimal time schedule [...].
Related Concept Videos
Urologic Endoscopic Procedure: Cystoscopic Examination
Kidney Transplant II: Surgical Procedure
Imaging Studies VI: Voiding Cystourethrography and Cystography
Urinary Tract Infection IV: Nursing Management
Appendicitis-II: Diagnostic Studies and Management
Diagnosing Appendicitis
It requires a multifaceted approach, starting with a detailed physical examination to pinpoint the location and nature of the pain and identify any associated symptoms. Laboratory tests play a crucial role. A complete Blood Count (CBC) typically reveals leukocytosis (an increased number of...
Urinary Tract Calculi VI: Surgical Management

